Lenalidomide,Idecabtagene vicleucel,Daratumumab,Pomalidomide,Dexamethasone,Bortezomib,Ixazomib,Carfilzomib,Elotuzumab
BMS,2Seventy Bio,Janssen,takeda,AbbVie
['karmma', 'karmma-3', 'ide-cel', 'mmsm']
#eha2023 | presents an analysis of ide-cel in tce rrmm, from the karmma-3 trial. ide-cel use resulted in increased orr, crr and pfs compared with soc regardless of high-risk status. #mmsm #myeloma 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma